i bc27f85be50b71b1 (31 page)

70 ACtJTE CARE HANDBOOK FOR PHYSICAL THERAI'ISTS

1 3. Bickley LS (ed). Bare's Guide to Physical Examination and History Taking (7th ed). Philadelphia, Lippincott, 1999.

14. Fersch T, Reinharr L, Wichter T, et al. Heart rate variability and electrical stability. Basic Res Cardiol 1 998;93:51 1 7-5124.

15. Kristal-Boneh E, Raifai M, Froom P, Ribak, j. Heart rate variability in

health and disease. 5cand J Work Environ Health 1995;2 1 :85-95.

16. Stein PK, Kleiger RE. Insights from the study of hearr rare variability.

Annu Rev Med 1 999;50:249-26 l .

17. Aigra A. Heart rate variability from 24-hour holter ecg and the 2 year

risk for sudden death. Circulation 1993;88: 1 80-1 85.

1 8. Dekker JM. Heart rate variability from short electrocardiographic

recordings predicts mortality from all causes in middle aged and elderly

men. Am J Epidemiol 1997;145:899-908.

19. Tusji H, Larson MG. Impact of reduced HRV on risk for cardiac events.

The Framingham Heart Study. Circulation 1 996;94:2850-2855.

20. Singh JP, Larson MG, Tsuji H, Ct al. Reduced heart rate variability and

new onset hypertension. Hypertension 1998;32:293-297.

2 1 . Bigger JT, La Rovere RT, Marcus FI, et al. Baroreflex sensitivity and

heart rate variability in prediction of total cardiac mortality after Ml.

Lancet 1 998;351 :478-484.

22. Bigger JT. Frequency domain measures of heart period variability and

mortality after myocardial infarction. Circulation 1992;85: 164-171.

23. Doulalas A, Flather MD, Pipilis A, Campbell S. Evolutionary pattern and prognostic importance of heart rate variability during the early phase of acute myocardial infarction. lnt J Cardiol 2001 ;77:

1 69-179.

24. Van Boven AJ, Crijns H, Haaksma J, Zwinderman AH. Depressed heart

rate variability is associated with events in patients with stable coronary

artery disease and preserved left ventricular dysfunction. Am Heart J

1998;135:571-576.

25. Galinier M, Pathak A, FourcadeJ, et al. Depressed low frequency power

of heart rate variability as an independent predictor of sudden cardiac

death in chronic heart failure. Eur Heart J 2000;21 :475-482.

26. Kleiger RE, Miller JP, Bigger TJ, Moss A. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1 987;59:256-262.

27. Polich S, Faynor SM. Interpreting lab test values. PT Magazine 1996;3:1 10.

28. Suzuki T, Yamauchi K, Yamada Y. Blood coaguability and fibrinolytic

activity before and after physical training during the recovery phase of

acute myocardial infarction. Clin Cardiol 1 992;1 5:358-364.

29. Grundy SM, Pasternak R, Greenland P, et al. Assessment of cardiovascular risk by use of multiple-risk-factOr assessment equations: a statement for healthcare professionals from the American Heart

Association and the American College of Cardiology. Circulation 1 999;

100: 1 4 8 1 - 1 492.

30. Christenson RH, Azzazy HME. Biochemical markers of the acute coronary syndromes. Clin Chern 1998; 44:1855-1864.

3 1 . Kratz AK, Leqand-Rowski KB. Normal reference laboratory values. N

Engl J Med 1998;339: 1063-1 072.

CARDIAC SYSTEM 71

32. Fisher EA, Stahl JA, Budd JH, Goldman ME. Transesophageal eohoeardiography: procedures and clinical application. J Am Coli Cardiol 1 99 1 ; 1 8: 1 333-1348.

33. Ellestad MH (cd). Stress Testing: Principles and Practice (4th ed). Philadelphia: FA Davis, 1 996.

34. Perez JE. Current role of contrast echocardiography in the diagnosis of

cardiovascular disease. Clin Cardiol 1 997;20:13 1-138.

35. Bellardmelli R, Geordiou 0, Prucaro A. Low dose dobutamine echocardiography predicts improvement in functional capacity after exercise training in patients with ischemic cardiomyopathy: prognostic implications. J Am Coli Cardiol 1 998;31 (5): I 027- 1 034.

36. American Heart Association, Committee on Exercise. Exercise Testing

and Training of Apparently Healrhy Individuals: A Handbook for Physi

Cians. Dallas, 1 972.

37. Brooks GA, Fahey m, White TP (eds). Exercise Physiology: Human

Bioenergetics and Its Applications (2nd ed). Mountain View, CA: Mayfield Publishing, 1 996.

38. Noonan V, Dean E. Submaximal exercise testing: clinical applications and

interpretation. Phys Ther 2000;80: 782-807.

39. American College of Cardiology/American Heart Association. 1 999

update: ACOAHA guidelines for the management of patienfs with

acute myocardial infarction: executive summary and recommendations.

Circulation 1 999; I 00: 1 0 1 6- 1 030.

40. American College of Cardiology/American Heart Association. ACa

AliA guidelines for the management of patients with acute myocardial

infarction. J Am Coli Cardiol 1 996;28: 1 328-1428.

4 1 . American College of Cardiology/American Heart Association. ACC/

AliA guidelines for the management of patients with unstable angina

and non-Sf segment elevation myocardial infarction. J Am Coli Cardiol

2000;36:97 1 - 1 048.

42. Cahaltn LP. Heart failure. Phys Ther 1 996;76:520.

43. American Heart Association. AHA MedicaUScientific Statement. 1 994

Revisions to Classification of Functional Capacity and Objective Assessment of Patients with Diseases of the Heart. Dallas: American Heart Association, 1 994.

44. Defre KM, Iioimes DR, Holudrov R, et al. Incidence and consequences

of periprocedural occlusion. Circulation 1 990;82:739.

45. Lirlak F. Margilis J, Cumins R. Excimer laser coronary (ECLA) registry:

report of the first 2080 patients. J Am Coli CardioI 1992;1 9:276A.

46. Humphrey R, Arena R. Surgical innovations for chronic heart failure

in the context of cardiopulmonary rehabilitation. Phys Ther 2000;

80,61-69.

47. Bernstein AD, Carnm AJ, Fletcher RD, er al. The NASPElBPEG generic

pacemaker code for antibradyarrhythmia and adaptive pacing and antitachyarrhythmia devices. PACE 1 987; 1 0:795.

48. Sharp cr, Busse EF, Burgess JJ, Haennel RG. Exercise prescription for

patients with pacemakers. J Cardiopulm Rehabil 1 998;18:421-43 1 .

49. Hayward MP. Dynamic cardiomyoplasty: time to wrap it up? IEditoriall. Heart 1 999;82:263.

72 AClJTE CARE HANDBOOK FOR I'HYSICAL THERAPISTS

50. Grimes K, Cohen M. Cardiac Medications. In EA Hillegass, HS Sadowsky (cds), Essentials of Cardiopulmonary Physical Therapy (2nd cd).

Philadelphia: Saunders, 2001 ;537-585.

5 1 . Cahalin LP, Ice RG, Lrwin S. Program Planning and Implementation. In

S Irwin, )S Tecklin (eds), Cardiopulmonary Physical Therapy (3rd ed).

St Louis: Mosby, 1995;144.

52. Wegener NK. Rehabilitation of the Patient with Coronary Heart Disease. In RC Schlant, RW Alexander (eds), Hurst's The Heart (8th ed).

New York: McGraw-Hili, 1994;1227.

Appendix 1-A